Date: 2025/01/29 - 10:31
Intensive blood pressure control for adults with hypertension and high cardiovascular risk can reduce the risk of mild cognitive impairment, and possibly dementia, in the long term, a new study confirms.
Date: 2025/01/28 - 15:31
A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes remission compared to just calorie restriction alone, new research has found.
Date: 2025/01/23 - 22:31
Following an "early" time-restricted intermittent fasting pattern is more beneficial for improved blood sugar regulation, and reducing the amount of abdominal fat just under the skin, a new study has found.
Date: 2025/01/22 - 00:32
A large study published in Nature Medicine reviewed the effects of GLP-1 drugs like Ozempic and Mounjaro on 175 different health outcomes. The findings show benefits for brain and heart health, but risks of developing gastrointestinal, kidney, and pancreatic issues.
Date: 2025/01/21 - 20:31
A new study compares the benefits and risks of taking GLP-1 medications for weight loss, including risks of dementia, addiction, heart disease, and gastrointestinal problems, among others.
Date: 2025/01/18 - 21:32
A new federal report shows that one drink per day is associated with negative health effects like liver cirrhosis and cancer, while a recent report from the surgeon general highlighted cancer risks associated with moderate alcohol consumption.